Integra LifeSciences Holdings (IART) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Integra LifeSciences Holdings (IART) is Neutral.

The composite score behind that read is -0.15, weighing +0.26 of bullish evidence against -0.38 bearish.

Integra LifeSciences Holdings last closed at $13.44, +0.22% on the session.

Against the IVW growth benchmark the position is -0.58% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

16 graded predictions for IART so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Integra LifeSciences Holdings in the 39th percentile on return on equity, where 100 is best.

Integra LifeSciences Holdings is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $1.04B.

StockMap tracks Integra LifeSciences Holdings as the 59th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Integra LifeSciences Holdings ranks 109th of 140 in the group, against a group median of -0.03.